在胸膜间皮瘤之后，腹膜间皮瘤在其它诊断中占多数。
After pleural mesothelioma, peritoneal mesothelioma accounts for the majority of other diagnoses.
结论弥漫性恶性腹膜间皮瘤有一定的超声特点，结合超声引导下活检能基本做出对该病的诊断与鉴别诊断。
Conclusions Diffuse malignant peritoneal mesothelioma, having the characteristic of ultrasonic image, can be grossly diagnosed in combination with the biopsy under the guidance of ultrasound.
目的：探讨应用腹腔镜手术诊治腹膜恶性间皮瘤的优势及可行性。
Objective:To explore the feasibility and advantage of applying laparoscopic technique to diagnose and treat peritoneum malignant mesothelioma.
目的探讨腹膜小细胞型恶性间皮瘤的临床与病理特征。
Objective To investigate the clinical and pathological characteristics of small cell malignant mesothelioma of the peritoneum (SCMMP).
间皮瘤是一种癌症的细胞，弥补衬砌周围以外的肺部内的肋骨(胸膜)，或周围腹部脏器(腹膜)。
Mesothelioma is a cancer of the cells that make up the lining around the outside of the lungs and inside of the ribs (pleura), or around the abdominal organs (peritoneum).
目的探讨腹膜恶性间皮瘤的超声表现及超声诊断价值。
Objective to study the sonographic findings of malignant peritoneal mesothelioma and the diagnostic value of ultrasound on it.
方法回顾性分析20例腹膜恶性间皮瘤的超声表现，并与8例腹膜转移癌及5例结核性腹膜炎声像图对比分析。
Methods The sonograms of 20 cases of malignant peritoneal mesothelioma, 8 cases of peritoneal metastatic tumor and 5 cases of peritoneal tuberculosis were analyzed.
其结果表明，恶性间皮瘤16例对S-100蛋白染色阳性者有14例，而腹膜转移性胃肠道腺癌均呈阴性。
Positive staining fors-100 protein was observed in 14 of 16 MM, while it was negative in all metastatic gastrointestinal adenocarcinoma of peritoneum.
目的：总结5例腹膜恶性间皮瘤的临床诊治经验。
Object:To summarize the clinical experience of diagnosis and treatment for 5 patients with malignant peritoneal mesothelioma.
腹膜恶性间皮瘤预后较差，综合治疗后中位生存期约1.5年。
The prognosis of PMM is bad. The meso life span is about 1.5 years after combined therapy.
腹膜恶性间皮瘤预后较差，综合治疗后中位生存期约1.5年。
The prognosis of PMM is bad. The meso life span is about 1.5 years after combined therapy.
应用推荐